|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
Conditions amenable to systemic glucocorticoid therapy, esp for acute situations.
Systemic therapy Peptic ulcers; systemic fungal infection; varicella & herpes genitalia infection; glaucoma. Local therapy Septic arthritis from gonorrhea or TB, instability of the joints. Hypersensitivity to glucocorticoids.
GI disorders; skin atrophy, acne; psychic disturbances, convulsions; glaucoma, increased intraocular pressure, posterior subcapsular cataracts; fluid & electrolyte disturbances; Cushing-like syndrome, premature epiphyseal closure, menstrual irregularities; myopathy, abdominal distension, osteoporosis, aseptic necrosis of femoral & humeral heads; following IV inj of large doses, transient burning or tingling sensation.
Hypokalemia w/ diuretics &/or cardiac glycosides. Reduced effectiveness w/ rifampicin, ephedrine, barbiturates, phenytoin & primidone. Alters effects of oral anticoagulant. NSAIDs may increase severity of GI ulceration. Antidiabetic agents & active vaccines.
Latent or overt cardiac failure, renal dysfunction, HTN, epilepsy, migraine; history of psychotic illness; latent TB; incomplete statural growth; live vaccines. Pregnancy, lactation; osteoporosis. Pregnancy: Hypokalemia w/ diuretics &/or cardiac glycosides. Reduced effectiveness w/ rifampicin, ephedrine, barbiturates, phenytoin & primidone. Alters effects of oral anticoagulant. NSAIDs may increase severity of GI ulceration. Antidiabetic agents & active vaccines. Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
SOLUTION FOR INJECTION
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Yaser Habrawi , F.R.C.S.Ed
Dr. Talal Sabouni
Dr. Faisal Dibsi
Dr. Tahsin Martini
Dr. Samer Al-Jneidy
Samir Moussa M.D.
Dr . Dirar Abboud
Dr. Hani Najjar